Estonian
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
pancreatitis/oksendamine
Link salvestatakse lõikelauale
9 tulemused
Substituted 1,4,-di-piperidin-4-yl-piperazine derivatives and their use as neurokinin antagonists
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
CROSS REFERENCE TO RELATED APPLICATIONS
This application is the national stage of Application No. PCT/EP2003/50697, filed Oct. 7, 2003, which application claims priority from PCT Patent Application No. PCT/EP02/11328 filed Oct. 8, 2002. and priority from PCT Patent Application No. PCT/EP02/14836
Substituted diaza-spiro-[4.5]-decane derivatives and their use as neurokinin antagonists
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
FIELD OF THE INVENTION
This invention concerns substituted diaza-spiro-[4.5]-decane derivatives having neurokinin antagonistic activity, in particular NK.sub.1 antagonistic activity, a combined NK.sub.1/NK.sub.2 antagonistic activity, a combined NK.sub.1/NK.sub.3 antagonistic activity and a combined
Diaza-spiro-{4,4}-nonane derivatives as neurokinin (NK.sub.1) antagonists
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
FIELD OF THE INVENTION
This invention concerns substituted diaza-spiro-[4.4]-nonane derivatives having neurokinin antagonistic activity, in particular NK.sub.1 antagonistic activity, their preparation, compositions comprising them and their use as a medicine, in particular for the treatment and/or
Substituted diaza-spiro-[5.5]-undecane derivatives and their use as neurokinin antagonists
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
CROSS REFERENCE TO RELATED APPLICATIONS
This application is the national stage of Application No. PCT/EP2005/051508, filed 4 Apr. 2005. which application claims priority from PCT/EP2004/050457 filed 6 Apr. 2004.
FIELD OF THE INVENTION
This invention concerns substituted diaza-spiro-[5.5]-undecane
Substituted oxa-diaza-spiro-[5.5]-undecanone derivatives and their use as neurokinin antagonists
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
CROSS-REFERENCE TO RELATED APPLICATIONS
This application is the National Stage of International Application No. PCT/EP2006/060419, filed Mar. 3, 2006, which claims the benefit of EP Application No. 05101657.4, filed Mar. 3, 2005, the disclosures of which are incorporated herein by reference in their
Macrocyclic antagonists of the motilin receptor for treatment of gastrointestinal dysmotility disorders
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
FIELD OF THE INVENTION
The present invention relates to novel conformationally-defined macrocyclic compounds that bind to and/or are functional modulators of the motilin receptor including subtypes, isoforms and/or variants thereof. These macrocyclic compounds possess appropriate pharmacological
Benzodiazepine derivatives
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
This invention relates to new benzodiazepine derivatives and pharmaceutically acceptable salts thereof.
More particularly, it relates to new benzodiazepine derivatives and pharmaceutically acceptable salts thereof which are cholecystokinin (CCK) antagonists and therefore can be used as therapeutical
Benzodiazepine derivatives
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
This invention relates to new benzodiazepine derivatives and pharmaceutically acceptable salts thereof.
More particularly, it relates to new benzodiazepine derivatives and pharmaceutically acceptable salts thereof which are cholecystokinin (CCK) antagonists and therefore can be used as therapeutical
Benzimidazolone derivatives
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
TECHNICAL FIELD
This invention relates to substituted benzimidazolone derivatives which are useful in the field of pharmaceuticals. More specifically, the invention relates to substituted benzimidazolone derivatives exhibiting selective antagonist activities against muscarinic acetylcholine receptor
Kõige täiuslikum ravimtaimede andmebaas, mida toetab teadus
- Töötab 55 keeles
- Taimsed ravimid, mida toetab teadus
- Maitsetaimede äratundmine pildi järgi
- Interaktiivne GPS-kaart - märgistage ürdid asukohas (varsti)
- Lugege oma otsinguga seotud teaduspublikatsioone
- Otsige ravimtaimi nende mõju järgi
- Korraldage oma huvisid ja hoidke end kursis uudisteuuringute, kliiniliste uuringute ja patentidega
Sisestage sümptom või haigus ja lugege ravimtaimede kohta, mis võivad aidata, tippige ürdi ja vaadake haigusi ja sümptomeid, mille vastu seda kasutatakse.
* Kogu teave põhineb avaldatud teaduslikel uuringutel
